Johnson & Johnson at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
All right. Good morning, everyone. My name is Danielle Antalffy, the medtech analyst here at UBS. And we are very lucky to have with us on this very exciting fireside chat the Johnson & Johnson Biosense Webster team. We are represented in full force here. Celine Martin, the company Group Chairman of CSS. Sorry, I guess, more than just Biosense Webster. We have Jasmina Brooks, the President of Biosense Webster; and Anthony Hong, VP Preclinical and Clinical Research and Medical Affairs. I know it's probably up there.
But anyway, thank you, guys, for joining. It's a very exciting time in electrophysiology and a lot is happening and a lot is going to happen over the next few months.
Questions & Answers
So maybe let's get a start, level setting. Biosense Webster is the very clear market leader today in electrophysiology. Can you talk, Celine, about how the EP market has evolved over the last decade?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
